SIGN UPLog In

General

Financials

Activity

Recent News
Corimmun
Corimmun
Company

Last deal

$10.36M
Local Amount - EUR 7.45M

Amount

Series B

Stage

31.10.2010

Date

3

all rounds

$18.41M

Total amount

date founded

Financing round

General

About Company
Corimmun is a German drug development company focused on therapeutics and diagnostics for heart and vascular diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2006

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Located in Martinsried near Munich, Germany, Corimmun was founded in 2006 and specializes in the research, development, and commercialization of novel therapeutics for congestive heart failure and atherosclerosis. With a focus on personalized medicine for cardiovascular diseases, Corimmun covers all stages of drug development, from research to commercialization.
Contacts

location

Martinsried, 82152 Planegg, Germany

Contact Email

Phone number

Website URL

http://www.corimmun.com
Similar Companies
1000
advanceCOR
advanceCORadvanceCOR is a clinical drug developing company focused on personalized therapies for heart and vascular diseases.
advanceCOR

advanceCOR

advanceCOR is a clinical drug developing company focused on personalized therapies for heart and vascular diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Health Diagnostics

Location

Munich, Germany

total rounds

1

total raised

$7.07M
Sayre Therapeutics
Sayre TherapeuticsSayre Therapeutics develops and sells drugs, devices, and diagnostics for cancer treatment.
Sayre Therapeutics

Sayre Therapeutics

Sayre Therapeutics develops and sells drugs, devices, and diagnostics for cancer treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Bengaluru, Karnataka, India

total rounds

2

total raised

$9M
TheraptosisTheraptosis is a biopharmaceutical company specializing in the development of drugs for cancer and neurodegenerative diseases.

Theraptosis

Theraptosis is a biopharmaceutical company specializing in the development of drugs for cancer and neurodegenerative diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

93230 Romainville, France

total rounds

1

total raised

$11.2M
Tenax Therapeutics
Tenax TherapeuticsTenax Therapeutics is a pharmaceutical company that develops products for cardiovascular and pulmonary diseases.
Tenax Therapeutics

Tenax Therapeutics

Tenax Therapeutics is a pharmaceutical company that develops products for cardiovascular and pulmonary diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Morrisville, NC, USA

total rounds

8

total raised

$92.69M

count Of Investments

1
M&A Details
1

Transaction name

Acquired by Janssen Belgium

Acquired by

Janssen Belgium
Janssen Belgium

Janssen Belgium

announced date

24.07.2012

Financials

Funding Rounds
3
3

Number of Funding Rounds

$18.41M

Money Raised

Their latest funding was raised on 31.10.2010. Their latest investor High-Tech Grunderfonds. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
31.10.2010
Series B
1
$10.36M
Local Amount - EUR 7.45M
MIG
MIG
20.09.2008
Series A
2
$7.18M
Local Amount - EUR 5M
—
22.01.2007
Seed
2
$880.71K
Local Amount - EUR 680K
—
MIG

MIG

MIG is a leading German VC investor focused on early to mid-stage technology and life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Neuherberg, Oberschleißheim, Germany

count Of Investments

72

count Of Exists

8
Co-Investors
Investors
3
1

Number of lead investors

3

Number of investors

Investor 
Lead 
Round 
Partners 
High-Tech Grunderfonds
High-Tech Grunderfonds
No
Seed, Series A
—
Bayern Kapital
Bayern Kapital
No
Seed
—
MIG
MIG
Yes
Series A, Series B
—
High-Tech Grunderfonds

High-Tech Grunderfonds

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Bonn, Germany

count Of Investments

828

count Of Exists

107
Bayern Kapital

Bayern Kapital

Bayern Kapital is a venture capital firm that finances research and development for high-tech companies in Bavaria.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Banking

Location

Landshut, Germany

count Of Investments

200

count Of Exists

24
MIG

MIG

MIG is a leading German VC investor focused on early to mid-stage technology and life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Neuherberg, Oberschleißheim, Germany

count Of Investments

72

count Of Exists

8

Activity

Recent News
0